Albemarle Corp (ALB)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NYSE
Market Cap: $11.04B
Last updated: Nov 17, 2026 at 11:05 AM ET
Albemarle Corp (ALB) Earnings: Report Dates and Results
Albemarle (ALB) is expected to report earnings on Feb 9, 2027. In the quarter ended Sep 30, 2026, Albemarle reported EPS of $2.58, above the $2.56 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ALB has an expected report date of Feb 9, 2027.
ALB Earnings Call
The latest ALB earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, ALB beat 33, missed 6 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $1.55B, up 18.3% from $1.31B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $2.58 | $2.56 | $1.72 - $3.40 | +0.78% | Beat | N/A | 16 | 2 up, 3 down | Nov 4, 2026 | $1.55B |
| Jun 30, 2026 | $3.75 | $3.35 | $2.78 - $4.02 | +11.94% | Beat | +3309.1% | 16 | 8 up, 1 down | Aug 5, 2026 | $1.74B |
| Mar 31, 2026 | $2.95 | $1.31 | $0.64 - $1.88 | +125.19% | Beat | N/A | 15 | 4 up, 1 down | May 6, 2026 | $1.43B |
| Dec 31, 2025 | -$0.53 | -$0.51 | -$0.98 - $0.16 | -3.33% | Miss | N/A | 17 | 5 up, 3 down | Feb 11, 2026 | $1.43B |
| Sep 30, 2025 | -$0.19 | -$0.92 | -$1.25 - -$0.38 | +79.35% | Beat | N/A | 17 | 4 up, 4 down | Nov 5, 2025 | $1.31B |
| Jun 30, 2025 | $0.11 | -$0.81 | -$1.50 - -$0.16 | +113.58% | Beat | +175.0% | 19 | 1 up, 7 down | Jul 30, 2025 | $1.33B |
| Mar 31, 2025 | -$0.18 | -$0.68 | -$1.27 - $0.14 | +73.53% | Beat | -169.2% | 16 | 1 up, 4 down | Apr 30, 2025 | $1.08B |
| Dec 31, 2024 | -$1.09 | -$0.67 | -$1.41 - $0.50 | -62.69% | Miss | -158.9% | 20 | 2 up, 5 down | Feb 12, 2025 | $1.23B |
| Sep 30, 2024 | -$1.55 | -$0.48 | -$1.24 - $0.46 | -222.92% | Miss | -156.6% | 19 | 1 up, 2 down | Nov 6, 2024 | $1.35B |
| Jun 30, 2024 | $0.04 | $0.46 | -$0.08 - $1.12 | -91.30% | Miss | -99.5% | 19 | 0 up, 2 down | Jul 31, 2024 | $1.43B |
| Mar 31, 2024 | $0.26 | $0.23 | -$0.66 - $2.32 | +13.04% | Beat | -97.5% | 20 | 4 up, 0 down | May 1, 2024 | $1.36B |
| Dec 31, 2023 | $1.85 | $1.11 | $0.03 - $2.10 | +66.67% | Beat | -78.5% | 19 | 0 up, 1 down | Feb 14, 2024 | $2.36B |
| Sep 30, 2023 | $2.74 | $3.74 | $2.17 - $8.18 | -26.74% | Miss | -63.5% | 20 | 3 up, 2 down | Nov 1, 2023 | $2.31B |
| Jun 30, 2023 | $7.33 | $4.52 | $3.27 - $6.00 | +62.17% | Beat | +112.5% | 18 | 4 up, 2 down | Aug 2, 2023 | $2.37B |
| Mar 31, 2023 | $10.32 | $7.04 | $6.17 - $8.21 | +46.59% | Beat | +333.6% | 19 | 1 up, 1 down | May 3, 2023 | $2.58B |
| Dec 31, 2022 | $8.62 | $8.37 | $7.23 - $9.65 | +2.99% | Beat | +753.5% | 20 | 13 up, 0 down | Feb 15, 2023 | $2.62B |
| Sep 30, 2022 | $7.50 | $6.99 | $5.49 - $8.57 | +7.30% | Beat | +614.3% | 18 | 2 up, 0 down | Nov 2, 2022 | $2.09B |
| Jun 30, 2022 | $3.45 | $3.25 | $2.28 - $3.79 | +6.15% | Beat | +287.6% | 16 | 4 up, 0 down | Aug 3, 2022 | $1.48B |
| Mar 31, 2022 | $2.38 | $1.65 | $1.29 - $2.17 | +44.24% | Beat | +116.4% | 18 | 4 up, 0 down | May 4, 2022 | $1.13B |
| Dec 31, 2021 | $1.01 | $0.99 | $0.92 - $1.14 | +2.02% | Beat | -13.7% | 17 | 2 up, 0 down | Feb 16, 2022 | $894.20M |
| Sep 30, 2021 | $1.05 | $0.77 | $0.64 - $0.95 | +36.36% | Beat | -3.7% | 20 | N/A | Nov 3, 2021 | $830.57M |
| Jun 30, 2021 | $0.89 | $0.83 | $0.65 - $1.14 | +7.23% | Beat | +3.5% | 20 | N/A | Aug 4, 2021 | $773.90M |
| Mar 31, 2021 | $1.10 | $0.80 | $0.60 - $0.99 | +37.50% | Beat | +10.0% | 20 | N/A | May 5, 2021 | $829.29M |
| Dec 31, 2020 | $1.17 | $1.12 | $0.90 - $1.33 | +4.46% | Beat | -32.4% | 20 | N/A | Feb 17, 2021 | $879.15M |
| Sep 30, 2020 | $1.09 | $0.76 | $0.68 - $1.01 | +43.42% | Beat | -28.8% | 19 | N/A | Nov 4, 2020 | $746.87M |
| Jun 30, 2020 | $0.86 | $0.72 | $0.43 - $0.93 | +19.44% | Beat | -44.5% | 19 | N/A | Aug 5, 2020 | $764.05M |
| Mar 31, 2020 | $1.00 | $0.84 | $0.71 - $1.05 | +19.05% | Beat | -18.7% | 19 | N/A | May 6, 2020 | $738.85M |
| Dec 31, 2019 | $1.73 | $1.75 | $1.56 - $1.84 | -1.14% | Miss | +13.1% | 19 | N/A | Feb 19, 2020 | $992.56M |
| Sep 30, 2019 | $1.53 | $1.50 | $1.35 - $1.78 | +2.00% | Beat | +16.8% | 21 | N/A | Nov 6, 2019 | $879.75M |
| Jun 30, 2019 | $1.55 | $1.43 | $1.30 - $1.62 | +8.39% | Beat | +14.0% | 21 | N/A | Aug 7, 2019 | $885.05M |
| Mar 31, 2019 | $1.23 | $1.23 | $1.20 - $1.25 | 0.00% | In line | -5.4% | 16 | N/A | May 8, 2019 | $832.06M |
| Dec 31, 2018 | $1.53 | $1.47 | $1.42 - $1.54 | +4.08% | Beat | +14.2% | 21 | N/A | Feb 20, 2019 | $921.70M |
| Sep 30, 2018 | $1.31 | $1.25 | $1.20 - $1.37 | +4.80% | Beat | +21.3% | 20 | N/A | Nov 7, 2018 | $777.75M |
| Jun 30, 2018 | $1.36 | $1.28 | $1.19 - $1.39 | +6.25% | Beat | +20.4% | 21 | N/A | Aug 7, 2018 | $853.87M |
| Mar 31, 2018 | $1.30 | $1.20 | $1.15 - $1.31 | +8.33% | Beat | +23.8% | 19 | N/A | May 9, 2018 | $821.63M |
| Dec 31, 2017 | $1.34 | $1.21 | $1.15 - $1.29 | +10.74% | Beat | +71.8% | 21 | N/A | Feb 27, 2018 | $857.79M |
| Sep 30, 2017 | $1.08 | $1.07 | $1.01 - $1.11 | +0.93% | Beat | +18.7% | 19 | N/A | Nov 8, 2017 | $754.87M |
| Jun 30, 2017 | $1.13 | $1.10 | $1.02 - $1.19 | +2.73% | Beat | +3.7% | 18 | N/A | Aug 7, 2017 | $737.26M |
| Mar 31, 2017 | $1.05 | $0.96 | N/A | +9.38% | Beat | -6.3% | N/A | N/A | May 3, 2017 | $722.06M |
| Dec 31, 2016 | $0.78 | $0.73 | N/A | +6.85% | Beat | -24.3% | N/A | N/A | Feb 27, 2017 | $696.65M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.79, after -$2.34 the year before. It was $3.90 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.79 | N/A |
| Dec 31, 2024 | -$2.34 | -110.5% |
| Dec 31, 2023 | $22.24 | +1.3% |
| Dec 31, 2022 | $21.95 | +442.0% |
| Dec 31, 2021 | $4.05 | -1.7% |
| Dec 31, 2020 | $4.12 | -31.8% |
| Dec 31, 2019 | $6.04 | +9.8% |
| Dec 31, 2018 | $5.50 | +19.6% |
| Dec 31, 2017 | $4.60 | +17.9% |
| Dec 31, 2016 | $3.90 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,900 words across 15 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,862 | 15 | |
| 2026Q2 | Jun 30, 2026 | 8,449 | 17 | |
| 2026Q1 | Mar 31, 2026 | 6,074 | 18 | |
| 2025Q4 | Dec 31, 2025 | 8,367 | 15 | |
| 2025Q3 | Sep 30, 2025 | 7,591 | 19 | |
| 2025Q2 | Jun 30, 2025 | 7,374 | 18 | |
| 2025Q1 | Mar 31, 2025 | 7,971 | 17 | |
| 2024Q4 | Dec 31, 2024 | 3,741 | 17 |
2026Q3 Earnings Call
Opening remarks
Meredith Bandy Vice President of Investor Relations and Sustainability Thank you, and welcome, everyone, to Albemarle's Third Quarter 2026 Earnings Conference Call. Our earnings were released after market close yesterday, and you'll find the press release and earnings presentation posted to our website under the Investors section at albemarle.com. Joining me on the call today are Kent Masters, Chairman and Chief Executive Officer, and Neal Sheorey, Chief Financial Officer. Eric Norris, Chief Commercial Officer, will also be available for Q&A. As a reminder, some of the statements made during this call, including our outlook, expected company performance, and strategic initiatives, may constitute forward-looking statements. Please note the cautionary language about forward-looking statements contained in our press release and earnings presentation. That same language applies to this call. Please also note that some of our comments today refer to non-GAAP financial measures. You'll find reconciliations in our earnings materials. And now I'll turn the call over to Kent.
Kent Masters Chairman and Chief Executive Officer Thank you, Meredith. Albemarle delivered another solid quarter, supported by disciplined execution across the enterprise. We reported third-quarter net sales of $1.6 billion and adjusted EBITDA of $646 million. Energy Storage results were supported by higher lithium pricing year over year, and Specialties outperformed with both higher pricing and volumes. Both segments are benefiting from ongoing cost and productivity efforts. Year to date, our teams have delivered more than $150 million in run-rate cost and productivity improvements, achieving the high end of our full-year target. Importantly, we have converted those strong earnings into cash. Year to date, we've generated $1.5 billion of cash from operations and $1.2 billion of free cash flow. Our year-to-date operating cash conversion rate of 67% is at the high end of our benchmarking range. We are also improving our 2026 outlook considerations. We are increasing our adjusted EBITDA outlook for Specialties based on strong year-to-date performance, steady market demand, and continued cost and productivity improvements. We are also reducing expected full-year capital expenditures through focused capital efficiency and the resequencing of some early-stage project spending. End-market fundamentals remain strong for both our businesses. Global lithium consumption increased 48% year to date, led by continued strong demand for energy storage systems and rebounding demand for electric vehicles. Lithium demand continues to outpace supply growth. Finally, at our world-class resources, the Greenbushes CGP3 expansion project achieved 30 days of nameplate performance in September. We are also progressing near-term growth opportunities at Greenbushes, Wodgina, and the Salar de Atacama. Now I'll turn it over to Neal to discuss our financial results and outlook. Then I'll return to cover market trends, our resource position, and a few closing comments before opening the call for Q&A.
Neal Sheorey Chief Financial Officer Thank you, Kent, and good morning, everyone. I'll begin with our third-quarter results on Slide 5.
Frequently Asked Questions About ALB
When is Albemarle's next earnings date?
Albemarle's next earnings report is expected for Feb 9, 2027.
Did ALB beat earnings estimates last quarter?
Yes. Albemarle reported EPS of $2.58 for the quarter ended Sep 30, 2026, above the $2.56 estimate, a 0.78% surprise.
What EPS do analysts expect from ALB next quarter?
The consensus EPS estimate for Albemarle for the quarter ending Dec 31, 2026 is $1.31 from 18 analysts, with estimates from $0.04 to $2.11.
How often does ALB beat earnings estimates?
Albemarle beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +42.29%.
ALB pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts